Independent Payment Advisory Board

American Bar Association Elects Amy Shulman to the Labor and Employment Law Section Council

Retrieved on: 
Martedì, Agosto 17, 2021
Worker Adjustment and Retraining Notification Act of 1988, Religion, ABA, Employment, Amy, Labour, Epidemic Response Committee, Leadership, LGBTQ, Transgender, Executive, Partnership, Dignity, Union, Council, Private law, Annual general meeting, Collective action in the United Kingdom, American Bar Association, Martin Lel, Advisory board, LEL, Financial services, Conference, Trade Union International of Banks, Insurance and Financial Unions Employees, Annual, Sex, International Labor Rights Forum, LLP, ERR, NELA, Section, Labor and Employment Relations Association, Department of Defense Whistleblower Program, Lawyer, Association, Employment Rights Act 1996, Disability, Sexual harassment, Multimedia, Workplace, Independent Payment Advisory Board, Labour law, Contract, Discrimination, Gender identity, Management

NEW YORK, Aug. 17, 2021 /PRNewswire/ -- Outten & Golden, LLP is proud to announce that Amy F. Shulman was elected to the American Bar Association's Labor and Employment Law (LEL) Section Council.

Key Points: 
  • NEW YORK, Aug. 17, 2021 /PRNewswire/ -- Outten & Golden, LLP is proud to announce that Amy F. Shulman was elected to the American Bar Association's Labor and Employment Law (LEL) Section Council.
  • "Giving back to the legal profession at the national level, especially the employment bar, is a tremendous privilege."
  • Specifically, Ms. Shulman will serve as a Council Member (Union & Employee), representing the LEL Section's constituency of employee-side and union-side employment attorneys.
  • The Section has more than 20,000 members across the U.S. who represent all perspectives of labor and employment law, including management, union, plaintiff, neutral, and public.

CareQuest Institute Applauds Senate Plan to Strengthen Medicare to Include Oral Health Care Benefit

Retrieved on: 
Mercoledì, Luglio 14, 2021
Publicly funded health care, Healthcare reform in the United States, Medicare, Health, Government, Institute for Family Health, Independent Payment Advisory Board

Last night, members of the Senate Budget Committee announced an agreement on an infrastructure package that would, among other things, expand the Medicare program to include an oral health care benefit.

Key Points: 
  • Last night, members of the Senate Budget Committee announced an agreement on an infrastructure package that would, among other things, expand the Medicare program to include an oral health care benefit.
  • CareQuest Institute for Oral Health CEO and President Dr. Myechia Minter-Jordan issued the following statement,applauding the Senate Budget Committee for itsinclusionof Medicare dental benefits:
    If we want to end the disparities in health care that have plagued our country for generations, then we must strengthen our Medicare program to include dental coverage.
  • CareQuest Institute for Oral Health is a national nonprofit championing a more equitable future where every person can reach their full potential through excellent health.
  • We collaborate with thought leaders, health care providers, patients, and local, state, and federal stakeholders to accelerate oral health care transformation and create a system designed for everyone.

Indian High Court in Chennai Delivers a Decisive Product Patent Victory to Kibow Biotech Inc Specializing in Kidney Health Supplement "Renadyl™" - the Flagship Product for its "Enteric Dialysis®" Platform Technology

Retrieved on: 
Venerdì, Febbraio 22, 2019
Health, Healthcare reform in the United States, Independent Payment Advisory Board, NDI, Validation, Dietary supplement, Supplement, Contents, Articles

La Renon had challenged the validity of Kibow's patent before India's specialized IP tribunal, the Intellectual Property Appellate Board (IPAB) in 2013.

Key Points: 
  • La Renon had challenged the validity of Kibow's patent before India's specialized IP tribunal, the Intellectual Property Appellate Board (IPAB) in 2013.
  • The Madras High Court has now validated the IPAB order and effectively upheld Kibow's patent once again.
  • Currently Renadyl https://renadyl.com/ is marketed and sold via its own online web site and on Amazon as a kidney health dietary supplement.
  • Kidney health supplement with a pharma-like validation: Kibow Biotech is not a pharmaceutical company.